ZYBAN

This brand name is authorized in Australia, Brazil, Canada, France, Ireland, Israel, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug ZYBAN contains one active pharmaceutical ingredient (API):

1 Bupropion UNII ZG7E5POY8O - BUPROPION HYDROCHLORIDE

Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms. Read about Bupropion

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYBAN Prolonged release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX12	Bupropion	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8465M, 8710K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510609401113315
Country: CA	Health Products and Food Branch	Identifier(s): 02238441
Country: FR	Base de données publique des médicaments	Identifier(s): 64556383
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147460, 164536, 19231, 373482
Country: IE	Health Products Regulatory Authority	Identifier(s): 29211, 56054
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4212
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 53643
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8829
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094624
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65215001, W65215002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522036073
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/34/0374